Sign In
Buy ICUI
$130.52
+0.0400 (+0.0307%)
At Close: Jun 03, 2026
ICUI Investors Have Opportunity to Join ICU Medical, Inc. Fraud Investigation with the Schall Law Firm
10:41pm, Thursday, 24'th Apr 2025
LOS ANGELES--(BUSINESS WIRE)--ICUI Investors Have Opportunity to Join ICU Medical, Inc. Fraud Investigation with the Schall Law Firm.
ICU Medical, Inc. Being Investigated on Behalf of ICU Medical, Inc. Investors. Contact Levi & Korsinsky For Details
04:30pm, Thursday, 24'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possibl
ICUI ALERT: ICU Medical, Inc. Investigated For Securities Fraud; Investors Should Contact Block & Leviton To Potentially Recover Losses
11:21am, Thursday, 24'th Apr 2025
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating ICU Medical, Inc. (Nasdaq: ICUI) for potential securities law violations. Investors who have lost money in their ICU Medical
ICU Medical Announces Time of First Quarter 2025 Earnings Conference Call
08:30am, Thursday, 24'th Apr 2025
SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of
ICU Medical, Inc. (ICUI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
05:56pm, Tuesday, 22'nd Apr 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI) investors concerning th
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI) on behalf of investors concerning
ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts
07:36am, Wednesday, 09'th Apr 2025
ICU Medical unveils a strategic plan to offset new U.S. tariffs, aiming to protect margins and stability amid medtech market volatility and global trade shifts.
ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps
01:05pm, Tuesday, 08'th Apr 2025
ICU Medical aims to enable healthcare systems to customize infusion setups, optimizing device footprint without compromising performance or safety.
ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps
08:00am, Monday, 07'th Apr 2025
New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. SAN CLEMENTE, Calif.
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference
08:30am, Monday, 24'th Mar 2025
SAN CLEMENTE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company manag
ICU Medical to Participate at the KeyBanc Healthcare Forum
08:40am, Friday, 07'th Mar 2025
SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company manag
ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call Transcript
10:57pm, Thursday, 27'th Feb 2025
ICU Medical, Inc. (NASDAQ:ICUI ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants John Mills - ICR, IR Vivek Jain - Chairman and CEO Brian Bonnell - Chief Financial O
ICU Medical (ICUI) Q4 Earnings and Revenues Top Estimates
07:25pm, Thursday, 27'th Feb 2025
ICU Medical (ICUI) came out with quarterly earnings of $2.11 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.57 per share a year ago.
ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance
04:05pm, Thursday, 27'th Feb 2025
SAN CLEMENTE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial res
ICU Medical to Present at the Raymond James 46th Annual Institutional Investors Conference
04:05pm, Thursday, 13'th Feb 2025
SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company manage
